SARAH DAVIS: Open Payments
NPI 1932155785 · SCOTTSDALE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,008 in 63 payments from 22 companies in 2025. Trend: 2023 $2,257 · 2024 $2,329 · 2025 $3,008
Food & beverage: $2,430Travel & lodging: $578
| Company | Payments | Amount |
|---|---|---|
| Bard Peripheral Vascular, Inc. | 7 | $862 |
| Edwards Lifesciences Corporation | 2 | $383 |
| E.R. Squibb & Sons, L.L.C. | 6 | $308 |
| AstraZeneca Pharmaceuticals LP | 3 | $307 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $237 |
| Esperion Therapeutics, Inc. | 9 | $179 |
| Novartis Pharmaceuticals Corporation | 11 | $162 |
| Boston Scientific Corporation | 1 | $152 |
| Novo Nordisk Inc | 1 | $91 |
| Alnylam Pharmaceuticals Inc. | 2 | $45 |
Products named: Venclose Maven Catheter, CAMZYOS, LOKELMA, JARDIANCE, SAPIEN 3 Ultra RESILIA, EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV), NEXLETOL, LEQVIO.
Industry payments across AZ — which companies pay providers there.
